Physician profile
Ryan W Rogers
NPI 1003015785
$3,842.30
in general payments reported to CMS, 2019-2025
12 companies · $1,003 in 2025
The $1,003 reported for 2025 was more than what 77% of Ophthalmology providers received nationally (typical 2025 total: $384).
Payments by year
General payments by program year, as reported to CMS.
General payments by year: 2022: $688 · 2023: $428 · 2024: $1,724 · 2025: $1,003.
What the payments were for
Nature of payment as categorized by the reporting companies: meals, consulting, travel, and so on.
Food and Beverage: $3,154.
View as a table
| Payment type | Amount (2023-2025) |
|---|---|
| Food and Beverage | $3,154.37 |
Payment-type detail covers 2023-2025; earlier years are included in totals but not broken out here.
Who reported paying
General payments only, as reported to CMS. Product names cover 2023-2025.
| Company | General payments | Years | Top products |
|---|---|---|---|
| Alcon Vision LLC | $570.61 | 2024-2025 | Rocklatan, Rhopressa, Tryptyr |
| Oyster Point Pharma, INC. | $515.70 | 2022-2024 | Tyrvaya, Ryzumvi |
| Bausch & Lomb Americas INC. | $497.32 | 2024-2025 | Xiidra, Miebo |
| Horizon Therapeutics Plc | $388.04 | 2022-2023 | Tepezza |
| Abbvie INC. | $305.38 | 2023-2025 | Vuity, Alphagan P, Lumigan |
| Biotissue Holdings INC. | $285.72 | 2024 | |
| Tarsus Pharmaceuticals, INC. | $267.79 | 2024-2025 | Xdemvy |
| Harrow Eye, LLC | $259.12 | 2024 | Vevye |
| Dompe US, INC. | $255.99 | 2023-2025 | Oxervate |
| Amgen INC. | $224.93 | 2024-2025 | Tepezza |
| Rxsight INC | $146.70 | 2025 | Rxsight Contact Lens, Light Adjustable Lens (Lal), Rxsight Injector Cartridge |
| Sight Sciences, INC. | $125.00 | 2025 | Sion Surgical Instrument, Omni Surgical System |
Drugs and devices associated with these payments
CMS records which products a payment was associated with, not how the money was allocated. Association is not allocation: one payment can be associated with several products, and a product listing does not mean the payment was made because of that product. Product detail covers 2023-2025.
If you want to bring it up
Most clinicians are glad to talk about this. A respectful way in:
- "I saw Ryan Rogers listed in the CMS Open Payments database. Can you tell me about your work with those companies?"
- "Is there a generic or alternative to this medication, and would it work as well for me?"
- "What made you choose this particular treatment for my situation?"
These are normal questions. A good clinician will welcome them.
Share this page
Keep an eye on this page
Get an email when the next June refresh changes this page. No account needed.
Source: CMS Open Payments, program years 2019-2025, as reported to CMS by drug and device makers (published June 30, 2026). Drug and device detail covers 2023-2025.